Skip to main content

WELLS FARGO & COMPANY/MN

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in BTAI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,114
+$327 QoQ
Shares Held
4,337
+0.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 47 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $472,275,691 across 58 Drug Manufacturers - Specialty & Generic names. BTAI ranks #49 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BTAI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,114 4,337
2026-03-31 $5,787 4,319
2025-12-31 $6,919 4,325
2025-09-30 $41,768 16,316
2025-06-30 $30,623 16,919
2025-03-31 $24,954 12,293
2024-12-31 $74,429 199,010
2024-09-30 $112,884 185,058
2024-06-30 $171,104 133,676
2024-03-31 $347,101 123,086
2023-12-31 $229,594 77,829
2023-09-30 $189,543 74,919
2023-06-30 $515,356 77,381
2023-03-31 $888,419 47,611
2022-12-31 $376,608 17,533
2022-09-30 $221,044 18,701
2022-06-30 $222,155 16,830
2022-03-31 $287,406 13,745
2021-12-31 $400,580 19,704
2021-09-30 $297,883 9,815
2021-06-30 $274,790 9,456
2021-03-31 $542,950 12,580
2020-12-31 $1,429,750 30,947
2020-09-30 $526,345 12,139
2020-06-30 $813,384 15,344
2020-03-31 $183,224 8,198